{"description":"Safety population: All participants who were enrolled and took at least 1 dose of study medication.\n\nThe initial data reported at Week 32 was based on MedDRA 15.1; the remaining data reported for end of study was based on MedDRA 20.1.","eventGroups":[{"description":"Starting dose of 10 mg BID with individualized dose titration ranging from 5 mg QD to 25 mg BID based on safety and efficacy","id":"EG000","otherNumAffected":105,"otherNumAtRisk":110,"seriousNumAffected":15,"seriousNumAtRisk":110,"title":"Ruxolitinib - Through Week 32"},{"description":"Best Available Therapy (BAT) will be selected by the Investigator for each participant. BAT may not include experimental agents (i.e. those not approved for the treatment of any indication) as well as a limited number of other selected drugs in accordance with the protocol-defined requirements.","id":"EG001","otherNumAffected":104,"otherNumAtRisk":111,"seriousNumAffected":10,"seriousNumAtRisk":111,"title":"Best Available Therapy - Through Week 32"},{"description":"Starting dose of 10 mg BID with individualized dose titration ranging from 5 mg QD to 25 mg BID based on safety and efficacy","id":"EG002","otherNumAffected":107,"otherNumAtRisk":110,"seriousNumAffected":44,"seriousNumAtRisk":110,"title":"Ruxolitinib - Week 256 Close Out"}],"frequencyThreshold":"5","otherEvents":[{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Blood and lymphatic system disorders","sourceVocabulary":"MedDRA 20.1","stats":[{"groupId":"EG000","numAffected":20,"numAtRisk":110},{"groupId":"EG001","numAffected":3,"numAtRisk":111},{"groupId":"EG002","numAffected":38,"numAtRisk":110}],"term":"Anaemia"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA 20.1","stats":[{"groupId":"EG000","numAffected":18,"numAtRisk":110},{"groupId":"EG001","numAffected":21,"numAtRisk":111},{"groupId":"EG002","numAffected":25,"numAtRisk":110}],"term":"Headache"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA 20.1","stats":[{"groupId":"EG000","numAffected":16,"numAtRisk":110},{"groupId":"EG001","numAffected":8,"numAtRisk":111},{"groupId":"EG002","numAffected":30,"numAtRisk":110}],"term":"Diarrhoea"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"General disorders","sourceVocabulary":"MedDRA 20.1","stats":[{"groupId":"EG000","numAffected":16,"numAtRisk":110},{"groupId":"EG001","numAffected":17,"numAtRisk":111},{"groupId":"EG002","numAffected":22,"numAtRisk":110}],"term":"Fatigue"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Skin and subcutaneous tissue disorders","sourceVocabulary":"MedDRA 20.1","stats":[{"groupId":"EG000","numAffected":15,"numAtRisk":110},{"groupId":"EG001","numAffected":25,"numAtRisk":111},{"groupId":"EG002","numAffected":30,"numAtRisk":110}],"term":"Pruritus"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA 20.1","stats":[{"groupId":"EG000","numAffected":13,"numAtRisk":110},{"groupId":"EG001","numAffected":11,"numAtRisk":111},{"groupId":"EG002","numAffected":17,"numAtRisk":110}],"term":"Dizziness"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Respiratory, thoracic and mediastinal disorders","sourceVocabulary":"MedDRA 20.1","stats":[{"groupId":"EG000","numAffected":11,"numAtRisk":110},{"groupId":"EG001","numAffected":2,"numAtRisk":111},{"groupId":"EG002","numAffected":19,"numAtRisk":110}],"term":"Dyspnoea"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Musculoskeletal and connective tissue disorders","sourceVocabulary":"MedDRA 20.1","stats":[{"groupId":"EG000","numAffected":13,"numAtRisk":110},{"groupId":"EG001","numAffected":5,"numAtRisk":111},{"groupId":"EG002","numAffected":22,"numAtRisk":110}],"term":"Muscle spasms"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Musculoskeletal and connective tissue disorders","sourceVocabulary":"MedDRA 20.1","stats":[{"groupId":"EG000","numAffected":8,"numAtRisk":110},{"groupId":"EG001","numAffected":7,"numAtRisk":111},{"groupId":"EG002","numAffected":24,"numAtRisk":110}],"term":"Arthralgia"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Respiratory, thoracic and mediastinal disorders","sourceVocabulary":"MedDRA 20.1","stats":[{"groupId":"EG000","numAffected":9,"numAtRisk":110},{"groupId":"EG001","numAffected":6,"numAtRisk":111},{"groupId":"EG002","numAffected":20,"numAtRisk":110}],"term":"Cough"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 20.1","stats":[{"groupId":"EG000","numAffected":10,"numAtRisk":110},{"groupId":"EG001","numAffected":9,"numAtRisk":111},{"groupId":"EG002","numAffected":19,"numAtRisk":110}],"term":"Nasopharyngitis"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Blood and lymphatic system disorders","sourceVocabulary":"MedDRA 20.1","stats":[{"groupId":"EG000","numAffected":9,"numAtRisk":110},{"groupId":"EG001","numAffected":12,"numAtRisk":111},{"groupId":"EG002","numAffected":19,"numAtRisk":110}],"term":"Thrombocytopenia"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Investigations","sourceVocabulary":"MedDRA 20.1","stats":[{"groupId":"EG000","numAffected":6,"numAtRisk":110},{"groupId":"EG001","numAffected":1,"numAtRisk":111},{"groupId":"EG002","numAffected":26,"numAtRisk":110}],"term":"Weight increased"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA 20.1","stats":[{"groupId":"EG000","numAffected":10,"numAtRisk":110},{"groupId":"EG001","numAffected":13,"numAtRisk":111},{"groupId":"EG002","numAffected":16,"numAtRisk":110}],"term":"Abdominal pain"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA 20.1","stats":[{"groupId":"EG000","numAffected":9,"numAtRisk":110},{"groupId":"EG001","numAffected":3,"numAtRisk":111},{"groupId":"EG002","numAffected":14,"numAtRisk":110}],"term":"Constipation"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 20.1","stats":[{"groupId":"EG000","numAffected":7,"numAtRisk":110},{"groupId":"EG001","numAffected":0,"numAtRisk":111},{"groupId":"EG002","numAffected":19,"numAtRisk":110}],"term":"Herpes zoster"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"General disorders","sourceVocabulary":"MedDRA 20.1","stats":[{"groupId":"EG000","numAffected":8,"numAtRisk":110},{"groupId":"EG001","numAffected":12,"numAtRisk":111},{"groupId":"EG002","numAffected":16,"numAtRisk":110}],"term":"Asthenia"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Musculoskeletal and connective tissue disorders","sourceVocabulary":"MedDRA 20.1","stats":[{"groupId":"EG000","numAffected":6,"numAtRisk":110},{"groupId":"EG001","numAffected":4,"numAtRisk":111},{"groupId":"EG002","numAffected":17,"numAtRisk":110}],"term":"Back pain"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Skin and subcutaneous tissue disorders","sourceVocabulary":"MedDRA 20.1","stats":[{"groupId":"EG000","numAffected":6,"numAtRisk":110},{"groupId":"EG001","numAffected":9,"numAtRisk":111},{"groupId":"EG002","numAffected":13,"numAtRisk":110}],"term":"Night sweats"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA 20.1","stats":[{"groupId":"EG000","numAffected":7,"numAtRisk":110},{"groupId":"EG001","numAffected":4,"numAtRisk":111},{"groupId":"EG002","numAffected":15,"numAtRisk":110}],"term":"Nausea"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"General disorders","sourceVocabulary":"MedDRA 20.1","stats":[{"groupId":"EG000","numAffected":7,"numAtRisk":110},{"groupId":"EG001","numAffected":7,"numAtRisk":111},{"groupId":"EG002","numAffected":9,"numAtRisk":110}],"term":"Oedema peripheral"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA 20.1","stats":[{"groupId":"EG000","numAffected":6,"numAtRisk":110},{"groupId":"EG001","numAffected":5,"numAtRisk":111},{"groupId":"EG002","numAffected":12,"numAtRisk":110}],"term":"Abdominal pain upper"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Respiratory, thoracic and mediastinal disorders","sourceVocabulary":"MedDRA 20.1","stats":[{"groupId":"EG000","numAffected":7,"numAtRisk":110},{"groupId":"EG001","numAffected":3,"numAtRisk":111},{"groupId":"EG002","numAffected":9,"numAtRisk":110}],"term":"Epistaxis"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Investigations","sourceVocabulary":"MedDRA 20.1","stats":[{"groupId":"EG000","numAffected":6,"numAtRisk":110},{"groupId":"EG001","numAffected":3,"numAtRisk":111},{"groupId":"EG002","numAffected":9,"numAtRisk":110}],"term":"Gamma-glutamyltransferase increased"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Vascular disorders","sourceVocabulary":"MedDRA 20.1","stats":[{"groupId":"EG000","numAffected":6,"numAtRisk":110},{"groupId":"EG001","numAffected":3,"numAtRisk":111},{"groupId":"EG002","numAffected":11,"numAtRisk":110}],"term":"Haematoma"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Ear and labyrinth disorders","sourceVocabulary":"MedDRA 20.1","stats":[{"groupId":"EG000","numAffected":6,"numAtRisk":110},{"groupId":"EG001","numAffected":3,"numAtRisk":111},{"groupId":"EG002","numAffected":9,"numAtRisk":110}],"term":"Tinnitus"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Psychiatric disorders","sourceVocabulary":"MedDRA 20.1","stats":[{"groupId":"EG000","numAffected":5,"numAtRisk":110},{"groupId":"EG001","numAffected":6,"numAtRisk":111},{"groupId":"EG002","numAffected":11,"numAtRisk":110}],"term":"Insomnia"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Musculoskeletal and connective tissue disorders","sourceVocabulary":"MedDRA 20.1","stats":[{"groupId":"EG000","numAffected":5,"numAtRisk":110},{"groupId":"EG001","numAffected":8,"numAtRisk":111},{"groupId":"EG002","numAffected":7,"numAtRisk":110}],"term":"Myalgia"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA 20.1","stats":[{"groupId":"EG000","numAffected":5,"numAtRisk":110},{"groupId":"EG001","numAffected":7,"numAtRisk":111},{"groupId":"EG002","numAffected":7,"numAtRisk":110}],"term":"Paraesthesia"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Metabolism and nutrition disorders","sourceVocabulary":"MedDRA 20.1","stats":[{"groupId":"EG000","numAffected":3,"numAtRisk":110},{"groupId":"EG001","numAffected":6,"numAtRisk":111},{"groupId":"EG002","numAffected":9,"numAtRisk":110}],"term":"Decreased appetite"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Musculoskeletal and connective tissue disorders","sourceVocabulary":"MedDRA 20.1","stats":[{"groupId":"EG000","numAffected":3,"numAtRisk":110},{"groupId":"EG001","numAffected":6,"numAtRisk":111},{"groupId":"EG002","numAffected":4,"numAtRisk":110}],"term":"Bone pain"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Ear and labyrinth disorders","sourceVocabulary":"MedDRA 20.1","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":110},{"groupId":"EG001","numAffected":0,"numAtRisk":111},{"groupId":"EG002","numAffected":7,"numAtRisk":110}],"term":"Vertigo"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA 20.1","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":110},{"groupId":"EG001","numAffected":0,"numAtRisk":111},{"groupId":"EG002","numAffected":6,"numAtRisk":110}],"term":"Abdominal distension"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA 20.1","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":110},{"groupId":"EG001","numAffected":0,"numAtRisk":111},{"groupId":"EG002","numAffected":7,"numAtRisk":110}],"term":"Dyspepsia"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA 20.1","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":110},{"groupId":"EG001","numAffected":0,"numAtRisk":111},{"groupId":"EG002","numAffected":6,"numAtRisk":110}],"term":"Vomiting"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"General disorders","sourceVocabulary":"MedDRA 20.1","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":110},{"groupId":"EG001","numAffected":0,"numAtRisk":111},{"groupId":"EG002","numAffected":7,"numAtRisk":110}],"term":"Oedema"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"General disorders","sourceVocabulary":"MedDRA 20.1","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":110},{"groupId":"EG001","numAffected":0,"numAtRisk":111},{"groupId":"EG002","numAffected":17,"numAtRisk":110}],"term":"Pyrexia"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 20.1","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":110},{"groupId":"EG001","numAffected":0,"numAtRisk":111},{"groupId":"EG002","numAffected":14,"numAtRisk":110}],"term":"Bronchitis"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 20.1","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":110},{"groupId":"EG001","numAffected":0,"numAtRisk":111},{"groupId":"EG002","numAffected":13,"numAtRisk":110}],"term":"Influenza"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 20.1","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":110},{"groupId":"EG001","numAffected":0,"numAtRisk":111},{"groupId":"EG002","numAffected":6,"numAtRisk":110}],"term":"Pharyngitis"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 15.1","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":110},{"groupId":"EG001","numAffected":0,"numAtRisk":111},{"groupId":"EG002","numAffected":10,"numAtRisk":110}],"term":"Upper respiratory tract infection"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 20.1","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":110},{"groupId":"EG001","numAffected":0,"numAtRisk":111},{"groupId":"EG002","numAffected":10,"numAtRisk":110}],"term":"Urinary tract infection"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Injury, poisoning and procedural complications","sourceVocabulary":"MedDRA 20.1","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":110},{"groupId":"EG001","numAffected":0,"numAtRisk":111},{"groupId":"EG002","numAffected":6,"numAtRisk":110}],"term":"Contusion"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Investigations","sourceVocabulary":"MedDRA 20.1","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":110},{"groupId":"EG001","numAffected":0,"numAtRisk":111},{"groupId":"EG002","numAffected":7,"numAtRisk":110}],"term":"Alanine aminotransferase increased"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Investigations","sourceVocabulary":"MedDRA 20.1","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":110},{"groupId":"EG001","numAffected":0,"numAtRisk":111},{"groupId":"EG002","numAffected":7,"numAtRisk":110}],"term":"Aspartate aminotransferase increased"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Investigations","sourceVocabulary":"MedDRA 20.1","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":110},{"groupId":"EG001","numAffected":0,"numAtRisk":111},{"groupId":"EG002","numAffected":6,"numAtRisk":110}],"term":"Blood cholesterol increased"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Musculoskeletal and connective tissue disorders","sourceVocabulary":"MedDRA 20.1","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":110},{"groupId":"EG001","numAffected":0,"numAtRisk":111},{"groupId":"EG002","numAffected":7,"numAtRisk":110}],"term":"Musculoskeletal pain"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Musculoskeletal and connective tissue disorders","sourceVocabulary":"MedDRA 20.1","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":110},{"groupId":"EG001","numAffected":0,"numAtRisk":111},{"groupId":"EG002","numAffected":6,"numAtRisk":110}],"term":"Osteoarthritis"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Musculoskeletal and connective tissue disorders","sourceVocabulary":"MedDRA 20.1","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":110},{"groupId":"EG001","numAffected":0,"numAtRisk":111},{"groupId":"EG002","numAffected":10,"numAtRisk":110}],"term":"Pain in extremity"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA 20.1","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":110},{"groupId":"EG001","numAffected":0,"numAtRisk":111},{"groupId":"EG002","numAffected":16,"numAtRisk":110}],"term":"Basal cell carcinoma"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA 20.1","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":110},{"groupId":"EG001","numAffected":0,"numAtRisk":111},{"groupId":"EG002","numAffected":8,"numAtRisk":110}],"term":"Myelofibrosis"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA 20.1","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":110},{"groupId":"EG001","numAffected":0,"numAtRisk":111},{"groupId":"EG002","numAffected":7,"numAtRisk":110}],"term":"Squamous cell carcinoma of skin"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA 20.1","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":110},{"groupId":"EG001","numAffected":0,"numAtRisk":111},{"groupId":"EG002","numAffected":6,"numAtRisk":110}],"term":"Hypoaesthesia"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA 20.1","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":110},{"groupId":"EG001","numAffected":0,"numAtRisk":111},{"groupId":"EG002","numAffected":6,"numAtRisk":110}],"term":"Neuralgia"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA 20.1","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":110},{"groupId":"EG001","numAffected":0,"numAtRisk":111},{"groupId":"EG002","numAffected":6,"numAtRisk":110}],"term":"Neuropathy peripheral"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Vascular disorders","sourceVocabulary":"MedDRA 20.1","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":110},{"groupId":"EG001","numAffected":0,"numAtRisk":111},{"groupId":"EG002","numAffected":17,"numAtRisk":110}],"term":"Hypertension"}],"seriousEvents":[{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Blood and lymphatic system disorders","sourceVocabulary":"MedDRA 15.1","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":110},{"groupId":"EG001","numAffected":0,"numAtRisk":111},{"groupId":"EG002","numAffected":1,"numAtRisk":110}],"term":"Leukocytosis"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Blood and lymphatic system disorders","sourceVocabulary":"MedDRA 20.1","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":110},{"groupId":"EG001","numAffected":0,"numAtRisk":111},{"groupId":"EG002","numAffected":1,"numAtRisk":110}],"term":"Neutropenia"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Cardiac disorders","sourceVocabulary":"MedDRA 20.1","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":110},{"groupId":"EG001","numAffected":1,"numAtRisk":111},{"groupId":"EG002","numAffected":3,"numAtRisk":110}],"term":"Atrial fibrillation"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Cardiac disorders","sourceVocabulary":"MedDRA 20.1","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":110},{"groupId":"EG001","numAffected":0,"numAtRisk":111},{"groupId":"EG002","numAffected":1,"numAtRisk":110}],"term":"Cardiac failure congestive"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Cardiac disorders","sourceVocabulary":"MedDRA 20.1","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":110},{"groupId":"EG001","numAffected":1,"numAtRisk":111},{"groupId":"EG002","numAffected":0,"numAtRisk":110}],"term":"Acute myocardial infarction"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Cardiac disorders","sourceVocabulary":"MedDRA 20.1","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":110},{"groupId":"EG001","numAffected":1,"numAtRisk":111},{"groupId":"EG002","numAffected":0,"numAtRisk":110}],"term":"Tachycardia"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Eye disorders","sourceVocabulary":"MedDRA 20.1","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":110},{"groupId":"EG001","numAffected":0,"numAtRisk":111},{"groupId":"EG002","numAffected":1,"numAtRisk":110}],"term":"Cataract"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Eye disorders","sourceVocabulary":"MedDRA 20.1","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":110},{"groupId":"EG001","numAffected":0,"numAtRisk":111},{"groupId":"EG002","numAffected":1,"numAtRisk":110}],"term":"Glaucoma"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Eye disorders","sourceVocabulary":"MedDRA 20.1","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":110},{"groupId":"EG001","numAffected":0,"numAtRisk":111},{"groupId":"EG002","numAffected":1,"numAtRisk":110}],"term":"Retinal detachment"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA 20.1","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":110},{"groupId":"EG001","numAffected":0,"numAtRisk":111},{"groupId":"EG002","numAffected":1,"numAtRisk":110}],"term":"Dental necrosis"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"General disorders","sourceVocabulary":"MedDRA 20.1","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":110},{"groupId":"EG001","numAffected":0,"numAtRisk":111},{"groupId":"EG002","numAffected":2,"numAtRisk":110}],"term":"Chest pain"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 20.1","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":110},{"groupId":"EG001","numAffected":0,"numAtRisk":111},{"groupId":"EG002","numAffected":1,"numAtRisk":110}],"term":"Bronchitis viral"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 20.1","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":110},{"groupId":"EG001","numAffected":1,"numAtRisk":111},{"groupId":"EG002","numAffected":1,"numAtRisk":110}],"term":"Diverticulitis"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 20.1","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":110},{"groupId":"EG001","numAffected":1,"numAtRisk":111},{"groupId":"EG002","numAffected":5,"numAtRisk":110}],"term":"Pneumonia"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 20.1","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":110},{"groupId":"EG001","numAffected":0,"numAtRisk":111},{"groupId":"EG002","numAffected":1,"numAtRisk":110}],"term":"Vulvovaginitis trichomonal"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 20.1","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":110},{"groupId":"EG001","numAffected":1,"numAtRisk":111},{"groupId":"EG002","numAffected":1,"numAtRisk":110}],"term":"Cellulitis"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 20.1","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":110},{"groupId":"EG001","numAffected":1,"numAtRisk":111},{"groupId":"EG002","numAffected":0,"numAtRisk":110}],"term":"Gastroenteritis"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Injury, poisoning and procedural complications","sourceVocabulary":"MedDRA 20.1","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":110},{"groupId":"EG001","numAffected":0,"numAtRisk":111},{"groupId":"EG002","numAffected":1,"numAtRisk":110}],"term":"Lumbar vertebral fracture"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Injury, poisoning and procedural complications","sourceVocabulary":"MedDRA 20.1","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":110},{"groupId":"EG001","numAffected":0,"numAtRisk":111},{"groupId":"EG002","numAffected":1,"numAtRisk":110}],"term":"Post procedural haemorrhage"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Injury, poisoning and procedural complications","sourceVocabulary":"MedDRA 20.1","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":110},{"groupId":"EG001","numAffected":0,"numAtRisk":111},{"groupId":"EG002","numAffected":1,"numAtRisk":110}],"term":"Splenic rupture"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Injury, poisoning and procedural complications","sourceVocabulary":"MedDRA 20.1","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":110},{"groupId":"EG001","numAffected":1,"numAtRisk":111},{"groupId":"EG002","numAffected":1,"numAtRisk":110}],"term":"Fall"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Injury, poisoning and procedural complications","sourceVocabulary":"MedDRA 20.1","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":110},{"groupId":"EG001","numAffected":1,"numAtRisk":111},{"groupId":"EG002","numAffected":0,"numAtRisk":110}],"term":"Subdural haematoma"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Metabolism and nutrition disorders","sourceVocabulary":"MedDRA 20.1","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":110},{"groupId":"EG001","numAffected":1,"numAtRisk":111},{"groupId":"EG002","numAffected":0,"numAtRisk":110}],"term":"Gout"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Musculoskeletal and connective tissue disorders","sourceVocabulary":"MedDRA 20.1","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":110},{"groupId":"EG001","numAffected":0,"numAtRisk":111},{"groupId":"EG002","numAffected":1,"numAtRisk":110}],"term":"Muscular weakness"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA 20.1","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":110},{"groupId":"EG001","numAffected":0,"numAtRisk":111},{"groupId":"EG002","numAffected":3,"numAtRisk":110}],"term":"Basal cell carcinoma"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA 20.1","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":110},{"groupId":"EG001","numAffected":0,"numAtRisk":111},{"groupId":"EG002","numAffected":1,"numAtRisk":110}],"term":"Acute leukaemia"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA 20.1","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":110},{"groupId":"EG001","numAffected":0,"numAtRisk":111},{"groupId":"EG002","numAffected":0,"numAtRisk":110}],"term":"Breast cancer"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA 20.1","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":110},{"groupId":"EG001","numAffected":0,"numAtRisk":111},{"groupId":"EG002","numAffected":1,"numAtRisk":110}],"term":"Myelofibrosis"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA 20.1","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":110},{"groupId":"EG001","numAffected":1,"numAtRisk":111},{"groupId":"EG002","numAffected":1,"numAtRisk":110}],"term":"Malignant melanoma"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA 15.1","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":110},{"groupId":"EG001","numAffected":0,"numAtRisk":111},{"groupId":"EG002","numAffected":1,"numAtRisk":110}],"term":"Neurological symptom"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Renal and urinary disorders","sourceVocabulary":"MedDRA 20.1","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":110},{"groupId":"EG001","numAffected":1,"numAtRisk":111},{"groupId":"EG002","numAffected":0,"numAtRisk":110}],"term":"Bladder disorder"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Respiratory, thoracic and mediastinal disorders","sourceVocabulary":"MedDRA 20.1","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":110},{"groupId":"EG001","numAffected":0,"numAtRisk":111},{"groupId":"EG002","numAffected":1,"numAtRisk":110}],"term":"Chronic obstructive pulmonary disease"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Respiratory, thoracic and mediastinal disorders","sourceVocabulary":"MedDRA 20.1","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":110},{"groupId":"EG001","numAffected":1,"numAtRisk":111},{"groupId":"EG002","numAffected":0,"numAtRisk":110}],"term":"Pulmonary embolism"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Vascular disorders","sourceVocabulary":"MedDRA 20.1","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":110},{"groupId":"EG001","numAffected":1,"numAtRisk":111},{"groupId":"EG002","numAffected":0,"numAtRisk":110}],"term":"Deep vein thrombosis"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA 20.1","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":110},{"groupId":"EG001","numAffected":0,"numAtRisk":111},{"groupId":"EG002","numAffected":4,"numAtRisk":110}],"term":"Squamous cell carcinoma"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Musculoskeletal and connective tissue disorders","sourceVocabulary":"MedDRA 20.1","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":110},{"groupId":"EG001","numAffected":0,"numAtRisk":111},{"groupId":"EG002","numAffected":3,"numAtRisk":110}],"term":"Intervertebral disc protrusion"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Metabolism and nutrition disorders","sourceVocabulary":"MedDRA 20.1","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":110},{"groupId":"EG001","numAffected":0,"numAtRisk":111},{"groupId":"EG002","numAffected":2,"numAtRisk":110}],"term":"Dehydration"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA 20.1","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":110},{"groupId":"EG001","numAffected":0,"numAtRisk":111},{"groupId":"EG002","numAffected":2,"numAtRisk":110}],"term":"Metastatic squamous cell carcinoma"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA 20.1","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":110},{"groupId":"EG001","numAffected":0,"numAtRisk":111},{"groupId":"EG002","numAffected":2,"numAtRisk":110}],"term":"Rectal haemorrhage"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA 20.1","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":110},{"groupId":"EG001","numAffected":0,"numAtRisk":111},{"groupId":"EG002","numAffected":2,"numAtRisk":110}],"term":"Squamous cell carcinoma of skin"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Blood and lymphatic system disorders","sourceVocabulary":"MedDRA 15.1","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":110},{"groupId":"EG001","numAffected":0,"numAtRisk":111},{"groupId":"EG002","numAffected":1,"numAtRisk":110}],"term":"Thrombocytopenia"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Cardiac disorders","sourceVocabulary":"MedDRA 20.1","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":110},{"groupId":"EG001","numAffected":0,"numAtRisk":111},{"groupId":"EG002","numAffected":1,"numAtRisk":110}],"term":"Atrioventricular block complete"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA 20.1","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":110},{"groupId":"EG001","numAffected":0,"numAtRisk":111},{"groupId":"EG002","numAffected":1,"numAtRisk":110}],"term":"Anal fistula"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA 20.1","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":110},{"groupId":"EG001","numAffected":0,"numAtRisk":111},{"groupId":"EG002","numAffected":1,"numAtRisk":110}],"term":"Gastric varices haemorrhage"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA 20.1","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":110},{"groupId":"EG001","numAffected":0,"numAtRisk":111},{"groupId":"EG002","numAffected":1,"numAtRisk":110}],"term":"Haematochezia"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA 20.1","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":110},{"groupId":"EG001","numAffected":0,"numAtRisk":111},{"groupId":"EG002","numAffected":1,"numAtRisk":110}],"term":"Ileus"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA 20.1","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":110},{"groupId":"EG001","numAffected":0,"numAtRisk":111},{"groupId":"EG002","numAffected":1,"numAtRisk":110}],"term":"Incarcerated inguinal hernia"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA 20.1","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":110},{"groupId":"EG001","numAffected":0,"numAtRisk":111},{"groupId":"EG002","numAffected":1,"numAtRisk":110}],"term":"Large intestinal stenosis"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA 20.1","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":110},{"groupId":"EG001","numAffected":0,"numAtRisk":111},{"groupId":"EG002","numAffected":1,"numAtRisk":110}],"term":"Varices oesophageal"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA 20.1","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":110},{"groupId":"EG001","numAffected":0,"numAtRisk":111},{"groupId":"EG002","numAffected":1,"numAtRisk":110}],"term":"Volvulus"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Hepatobiliary disorders","sourceVocabulary":"MedDRA 20.1","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":110},{"groupId":"EG001","numAffected":0,"numAtRisk":111},{"groupId":"EG002","numAffected":1,"numAtRisk":110}],"term":"Cholecystitis acute"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Hepatobiliary disorders","sourceVocabulary":"MedDRA 20.1","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":110},{"groupId":"EG001","numAffected":0,"numAtRisk":111},{"groupId":"EG002","numAffected":1,"numAtRisk":110}],"term":"Cholelithiasis"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 20.1","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":110},{"groupId":"EG001","numAffected":0,"numAtRisk":111},{"groupId":"EG002","numAffected":1,"numAtRisk":110}],"term":"Appendicitis"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 20.1","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":110},{"groupId":"EG001","numAffected":0,"numAtRisk":111},{"groupId":"EG002","numAffected":1,"numAtRisk":110}],"term":"Herpes zoster"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 20.1","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":110},{"groupId":"EG001","numAffected":0,"numAtRisk":111},{"groupId":"EG002","numAffected":1,"numAtRisk":110}],"term":"Lung infection"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 20.1","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":110},{"groupId":"EG001","numAffected":0,"numAtRisk":111},{"groupId":"EG002","numAffected":1,"numAtRisk":110}],"term":"Osteomyelitis"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 20.1","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":110},{"groupId":"EG001","numAffected":0,"numAtRisk":111},{"groupId":"EG002","numAffected":1,"numAtRisk":110}],"term":"Peritonitis"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 20.1","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":110},{"groupId":"EG001","numAffected":0,"numAtRisk":111},{"groupId":"EG002","numAffected":1,"numAtRisk":110}],"term":"Sepsis"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 20.1","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":110},{"groupId":"EG001","numAffected":0,"numAtRisk":111},{"groupId":"EG002","numAffected":1,"numAtRisk":110}],"term":"Staphylococcal infection"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 20.1","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":110},{"groupId":"EG001","numAffected":0,"numAtRisk":111},{"groupId":"EG002","numAffected":1,"numAtRisk":110}],"term":"Tooth abscess"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 20.1","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":110},{"groupId":"EG001","numAffected":0,"numAtRisk":111},{"groupId":"EG002","numAffected":1,"numAtRisk":110}],"term":"Urinary tract infection"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Injury, poisoning and procedural complications","sourceVocabulary":"MedDRA 20.1","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":110},{"groupId":"EG001","numAffected":0,"numAtRisk":111},{"groupId":"EG002","numAffected":1,"numAtRisk":110}],"term":"Post procedural haematoma"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Injury, poisoning and procedural complications","sourceVocabulary":"MedDRA 20.1","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":110},{"groupId":"EG001","numAffected":0,"numAtRisk":111},{"groupId":"EG002","numAffected":1,"numAtRisk":110}],"term":"Rib fracture"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Musculoskeletal and connective tissue disorders","sourceVocabulary":"MedDRA 20.1","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":110},{"groupId":"EG001","numAffected":0,"numAtRisk":111},{"groupId":"EG002","numAffected":1,"numAtRisk":110}],"term":"Lumbar spinal stenosis"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Musculoskeletal and connective tissue disorders","sourceVocabulary":"MedDRA 20.1","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":110},{"groupId":"EG001","numAffected":0,"numAtRisk":111},{"groupId":"EG002","numAffected":1,"numAtRisk":110}],"term":"Musculoskeletal pain"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Musculoskeletal and connective tissue disorders","sourceVocabulary":"MedDRA 20.1","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":110},{"groupId":"EG001","numAffected":0,"numAtRisk":111},{"groupId":"EG002","numAffected":1,"numAtRisk":110}],"term":"Spondylolisthesis"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA 20.1","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":110},{"groupId":"EG001","numAffected":0,"numAtRisk":111},{"groupId":"EG002","numAffected":1,"numAtRisk":110}],"term":"Adenocarcinoma gastric"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA 20.1","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":110},{"groupId":"EG001","numAffected":0,"numAtRisk":111},{"groupId":"EG002","numAffected":1,"numAtRisk":110}],"term":"Carcinoma in situ of skin"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA 20.1","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":110},{"groupId":"EG001","numAffected":0,"numAtRisk":111},{"groupId":"EG002","numAffected":1,"numAtRisk":110}],"term":"Chronic myeloid leukaemia"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA 20.1","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":110},{"groupId":"EG001","numAffected":0,"numAtRisk":111},{"groupId":"EG002","numAffected":1,"numAtRisk":110}],"term":"Hairy cell leukaemia"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA 20.1","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":110},{"groupId":"EG001","numAffected":0,"numAtRisk":111},{"groupId":"EG002","numAffected":1,"numAtRisk":110}],"term":"Invasive ductal breast carcinoma"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA 20.1","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":110},{"groupId":"EG001","numAffected":0,"numAtRisk":111},{"groupId":"EG002","numAffected":1,"numAtRisk":110}],"term":"Keratoacanthoma"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA 20.1","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":110},{"groupId":"EG001","numAffected":0,"numAtRisk":111},{"groupId":"EG002","numAffected":1,"numAtRisk":110}],"term":"Mediastinum neoplasm"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA 20.1","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":110},{"groupId":"EG001","numAffected":0,"numAtRisk":111},{"groupId":"EG002","numAffected":1,"numAtRisk":110}],"term":"Metastases to central nervous system"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA 20.1","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":110},{"groupId":"EG001","numAffected":0,"numAtRisk":111},{"groupId":"EG002","numAffected":1,"numAtRisk":110}],"term":"Metastasis"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA 20.1","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":110},{"groupId":"EG001","numAffected":0,"numAtRisk":111},{"groupId":"EG002","numAffected":1,"numAtRisk":110}],"term":"Neoplasm malignant"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA 20.1","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":110},{"groupId":"EG001","numAffected":0,"numAtRisk":111},{"groupId":"EG002","numAffected":1,"numAtRisk":110}],"term":"Prostate cancer"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA 20.1","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":110},{"groupId":"EG001","numAffected":0,"numAtRisk":111},{"groupId":"EG002","numAffected":1,"numAtRisk":110}],"term":"Rectosigmoid cancer"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA 20.1","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":110},{"groupId":"EG001","numAffected":0,"numAtRisk":111},{"groupId":"EG002","numAffected":1,"numAtRisk":110}],"term":"Cerebral infarction"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA 20.1","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":110},{"groupId":"EG001","numAffected":0,"numAtRisk":111},{"groupId":"EG002","numAffected":1,"numAtRisk":110}],"term":"Metabolic encephalopathy"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Psychiatric disorders","sourceVocabulary":"MedDRA 15.1","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":110},{"groupId":"EG001","numAffected":0,"numAtRisk":111},{"groupId":"EG002","numAffected":1,"numAtRisk":110}],"term":"Attention deficit/hyperactivity disorder"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Renal and urinary disorders","sourceVocabulary":"MedDRA 20.1","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":110},{"groupId":"EG001","numAffected":0,"numAtRisk":111},{"groupId":"EG002","numAffected":1,"numAtRisk":110}],"term":"Acute kidney injury"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Respiratory, thoracic and mediastinal disorders","sourceVocabulary":"MedDRA 20.1","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":110},{"groupId":"EG001","numAffected":0,"numAtRisk":111},{"groupId":"EG002","numAffected":1,"numAtRisk":110}],"term":"Atelectasis"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Respiratory, thoracic and mediastinal disorders","sourceVocabulary":"MedDRA 20.1","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":110},{"groupId":"EG001","numAffected":0,"numAtRisk":111},{"groupId":"EG002","numAffected":1,"numAtRisk":110}],"term":"Respiratory failure"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Vascular disorders","sourceVocabulary":"MedDRA 20.1","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":110},{"groupId":"EG001","numAffected":0,"numAtRisk":111},{"groupId":"EG002","numAffected":1,"numAtRisk":110}],"term":"Hypotension"}],"timeFrame":"The initial data reported was for the study up to Week 32. This time frame defines the comparative phase of the study where the majority of participants remained on their original randomized assignment and exposure between ruxolitinib and best available therapy was similar. Data inclusive of end of study was reported up to week 256 for Ruxolitinib group. Long term Follow Up for BAT was not reported as all patients have completed the study or crossed over to Ruxolitinib group by week 80."}